JDLA
PYXS icon

J. Derek Lewis & Associates’s Pyxis Oncology PYXS Stock Holding History

J. Derek Lewis & Associates’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Sell
42,000
-1,000
-2% -$1.91K 0.02% 195
2026
Q1 		$62.8K Sell
43,000
-10,000
-19% -$15.1K 0.01% 197
2025
Q4 		$61K Buy
+53,000
New +$187K 0.01% 201

Other funds holding PYXS

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

J. Derek Lewis & Associates's PYXS Position: Q2 2026 in Review

J. Derek Lewis & Associates reduced its Pyxis Oncology (PYXS) stake by 2.3% in Q2 2026, selling an estimated $1.91K and leaving 42,000 shares worth $126K. The position accounts for 0.02% of the portfolio, ranked #195.

J. Derek Lewis & Associates first reported a position in PYXS in Q4 2025 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • J. Derek Lewis & Associates held 42,000 shares of Pyxis Oncology worth $126K as of Q2 2026.
  • J. Derek Lewis & Associates sold 1,000 Pyxis Oncology shares in Q2 2026, an estimated $1.91K.
  • Pyxis Oncology made up 0.02% of J. Derek Lewis & Associates's portfolio in Q2 2026, its #195 holding.
  • J. Derek Lewis & Associates first reported a position in Pyxis Oncology in Q4 2025 and has held it in 3 quarters since.
  • 19 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on J. Derek Lewis & Associates's 13F filing for Q2 2026, filed 31 Jul 2026.